Pet Cancer Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global pet cancer therapeutics market reached a value of US$ 245.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 435.2 Million by 2027, exhibiting a CAGR of 10.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Pet cancer therapeutics refer to the diagnosis and treatment alternatives for cancerous and tumor growth in domesticated animals. It involves the treatment of lymphoma, mast cell cancer, melanoma and mammary and squamous cell cancer in dogs, cats and other pet animals. Some of the commonly used therapeutics include chemotherapy, immunotherapy, radiation therapy and biopsy. These therapies gradually neutralize or shrink the cancer cells using plant- and bacteria-based drugs and prevent the tumor from affecting the other parts of the body. The drugs are administered orally or injected intravenously, under the skin or into a muscle or the tumor. They are mixed with the food or treats to mask the flavor and make it more appealing for the pets.
Pet Cancer Therapeutics Market Trends:
The increasing prevalence of cancer in animals across the globe is one of the key factors driving the growth of the market. Moreover, the rising domestication of animals and increasing concerns regarding pet health among the masses are providing a thrust to the market growth. Leukemia and lymphoma are highly common in cats and certain breeds of aging dogs and can be caused by prolonged exposure to ultraviolet (UV) rays, second-hand tobacco smoke, herbicides, pesticides, insecticides and air pollution. In line with this, the increasing awareness regarding the benefits of timely diagnosis and available treatment alternatives is contributing to the growth of the market. Various technological advancements, such as the development of highly targeted and specific therapies for animal cancer treatment with minimal side effects, are also favoring the market growth. Other factors, including rising expenditure capacities of the consumers on pet healthcare, along with extensive research and development (R&D) activities in the field of veterinary oncology, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pet cancer therapeutics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapy, animal species, cancer type and end user.
Breakup by Therapy:
Chemotherapy
Radiation Therapy
Immunotherapy
Combination Therapy
Others
Breakup by Animal Species:
Cats
Dogs
Others
Breakup by Cancer Type:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
Breakup by End User:
Veterinary Hospitals and Clinical Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, ELIAS Animal Health LLC, Karyopharm Therapeutics, Pfizer Inc., Regeneus Ltd., Rhizen Pharmaceuticals AG, Torigen Pharmaceuticals Inc., VetDC Inc., Virbac and Zoetis Inc.
Key Questions Answered in This Report:
How has the global pet cancer therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pet cancer therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the therapy?
What is the breakup of the market based on the animal species?
What is the breakup of the market based on the cancer type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pet cancer therapeutics market and who are the key players?
What is the degree of competition in the industry?
Pet cancer therapeutics refer to the diagnosis and treatment alternatives for cancerous and tumor growth in domesticated animals. It involves the treatment of lymphoma, mast cell cancer, melanoma and mammary and squamous cell cancer in dogs, cats and other pet animals. Some of the commonly used therapeutics include chemotherapy, immunotherapy, radiation therapy and biopsy. These therapies gradually neutralize or shrink the cancer cells using plant- and bacteria-based drugs and prevent the tumor from affecting the other parts of the body. The drugs are administered orally or injected intravenously, under the skin or into a muscle or the tumor. They are mixed with the food or treats to mask the flavor and make it more appealing for the pets.
Pet Cancer Therapeutics Market Trends:
The increasing prevalence of cancer in animals across the globe is one of the key factors driving the growth of the market. Moreover, the rising domestication of animals and increasing concerns regarding pet health among the masses are providing a thrust to the market growth. Leukemia and lymphoma are highly common in cats and certain breeds of aging dogs and can be caused by prolonged exposure to ultraviolet (UV) rays, second-hand tobacco smoke, herbicides, pesticides, insecticides and air pollution. In line with this, the increasing awareness regarding the benefits of timely diagnosis and available treatment alternatives is contributing to the growth of the market. Various technological advancements, such as the development of highly targeted and specific therapies for animal cancer treatment with minimal side effects, are also favoring the market growth. Other factors, including rising expenditure capacities of the consumers on pet healthcare, along with extensive research and development (R&D) activities in the field of veterinary oncology, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pet cancer therapeutics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapy, animal species, cancer type and end user.
Breakup by Therapy:
Chemotherapy
Radiation Therapy
Immunotherapy
Combination Therapy
Others
Breakup by Animal Species:
Cats
Dogs
Others
Breakup by Cancer Type:
Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others
Breakup by End User:
Veterinary Hospitals and Clinical Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, ELIAS Animal Health LLC, Karyopharm Therapeutics, Pfizer Inc., Regeneus Ltd., Rhizen Pharmaceuticals AG, Torigen Pharmaceuticals Inc., VetDC Inc., Virbac and Zoetis Inc.
Key Questions Answered in This Report:
How has the global pet cancer therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global pet cancer therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the therapy?
What is the breakup of the market based on the animal species?
What is the breakup of the market based on the cancer type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global pet cancer therapeutics market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL PET CANCER THERAPEUTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY THERAPY
6.1 Chemotherapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Radiation Therapy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunotherapy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Combination Therapy
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY ANIMAL SPECIES
7.1 Cats
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Dogs
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY CANCER TYPE
8.1 Lymphoma
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Mast Cell Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Melanoma
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Mammary and Squamous Cell Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Veterinary Hospitals and Clinical Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AB Science
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Boehringer Ingelheim International GmbH
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.3 Elanco Animal Health Incorporated
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 ELIAS Animal Health LLC
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Karyopharm Therapeutics
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Pfizer Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Regeneus Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Rhizen Pharmaceuticals AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Torigen Pharmaceuticals Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 VetDC Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Virbac
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Zoetis Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL PET CANCER THERAPEUTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY THERAPY
6.1 Chemotherapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Radiation Therapy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunotherapy
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Combination Therapy
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY ANIMAL SPECIES
7.1 Cats
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Dogs
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY CANCER TYPE
8.1 Lymphoma
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Mast Cell Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Melanoma
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Mammary and Squamous Cell Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Veterinary Hospitals and Clinical Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AB Science
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Boehringer Ingelheim International GmbH
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.3 Elanco Animal Health Incorporated
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 ELIAS Animal Health LLC
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Karyopharm Therapeutics
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Pfizer Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Regeneus Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Rhizen Pharmaceuticals AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Torigen Pharmaceuticals Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 VetDC Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Virbac
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Zoetis Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Pet Cancer Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Therapy (in Million US$), 2022-2027
Table 3: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Animal Species (in Million US$), 2022-2027
Table 4: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Cancer Type (in Million US$), 2022-2027
Table 5: Global: Pet Cancer Therapeutics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Pet Cancer Therapeutics Market: Competitive Structure
Table 8: Global: Pet Cancer Therapeutics Market: Key Players
Table 1: Global: Pet Cancer Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Therapy (in Million US$), 2022-2027
Table 3: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Animal Species (in Million US$), 2022-2027
Table 4: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Cancer Type (in Million US$), 2022-2027
Table 5: Global: Pet Cancer Therapeutics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Pet Cancer Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Pet Cancer Therapeutics Market: Competitive Structure
Table 8: Global: Pet Cancer Therapeutics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Pet Cancer Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Pet Cancer Therapeutics Market: Breakup by Therapy (in %), 2021
Figure 5: Global: Pet Cancer Therapeutics Market: Breakup by Animal Species (in %), 2021
Figure 6: Global: Pet Cancer Therapeutics Market: Breakup by Cancer Type (in %), 2021
Figure 7: Global: Pet Cancer Therapeutics Market: Breakup by End User (in %), 2021
Figure 8: Global: Pet Cancer Therapeutics Market: Breakup by Region (in %), 2021
Figure 9: Global: Pet Cancer Therapeutics (Chemotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Pet Cancer Therapeutics (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Pet Cancer Therapeutics (Radiation Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Pet Cancer Therapeutics (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Pet Cancer Therapeutics (Immunotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Pet Cancer Therapeutics (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Pet Cancer Therapeutics (Combination Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Pet Cancer Therapeutics (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Pet Cancer Therapeutics (Other Therapies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Pet Cancer Therapeutics (Other Therapies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Pet Cancer Therapeutics (Cats) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Pet Cancer Therapeutics (Cats) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Pet Cancer Therapeutics (Dogs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Pet Cancer Therapeutics (Dogs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Pet Cancer Therapeutics (Other Animal Species) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Pet Cancer Therapeutics (Other Animal Species) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Pet Cancer Therapeutics (Lymphoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Pet Cancer Therapeutics (Lymphoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Pet Cancer Therapeutics (Mast Cell Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Pet Cancer Therapeutics (Mast Cell Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Pet Cancer Therapeutics (Melanoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Pet Cancer Therapeutics (Melanoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Pet Cancer Therapeutics (Mammary and Squamous Cell Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Pet Cancer Therapeutics (Mammary and Squamous Cell Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Pet Cancer Therapeutics (Other Cancer Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Pet Cancer Therapeutics (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Pet Cancer Therapeutics (Veterinary Hospitals and Clinical Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Pet Cancer Therapeutics (Veterinary Hospitals and Clinical Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Pet Cancer Therapeutics (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Pet Cancer Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Pet Cancer Therapeutics (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Pet Cancer Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Pet Cancer Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Pet Cancer Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia-Pacific: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia-Pacific: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Pet Cancer Therapeutics Market: Breakup by Country (in %), 2021
Figure 91: Middle East and Africa: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Global: Pet Cancer Therapeutics Industry: SWOT Analysis
Figure 93: Global: Pet Cancer Therapeutics Industry: Value Chain Analysis
Figure 94: Global: Pet Cancer Therapeutics Industry: Porter's Five Forces Analysis
Figure 1: Global: Pet Cancer Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Pet Cancer Therapeutics Market: Breakup by Therapy (in %), 2021
Figure 5: Global: Pet Cancer Therapeutics Market: Breakup by Animal Species (in %), 2021
Figure 6: Global: Pet Cancer Therapeutics Market: Breakup by Cancer Type (in %), 2021
Figure 7: Global: Pet Cancer Therapeutics Market: Breakup by End User (in %), 2021
Figure 8: Global: Pet Cancer Therapeutics Market: Breakup by Region (in %), 2021
Figure 9: Global: Pet Cancer Therapeutics (Chemotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Pet Cancer Therapeutics (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Pet Cancer Therapeutics (Radiation Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Pet Cancer Therapeutics (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Pet Cancer Therapeutics (Immunotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Pet Cancer Therapeutics (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Pet Cancer Therapeutics (Combination Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Pet Cancer Therapeutics (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Pet Cancer Therapeutics (Other Therapies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Pet Cancer Therapeutics (Other Therapies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Pet Cancer Therapeutics (Cats) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Pet Cancer Therapeutics (Cats) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Pet Cancer Therapeutics (Dogs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Pet Cancer Therapeutics (Dogs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Pet Cancer Therapeutics (Other Animal Species) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Pet Cancer Therapeutics (Other Animal Species) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Pet Cancer Therapeutics (Lymphoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Pet Cancer Therapeutics (Lymphoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Pet Cancer Therapeutics (Mast Cell Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Pet Cancer Therapeutics (Mast Cell Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Pet Cancer Therapeutics (Melanoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Pet Cancer Therapeutics (Melanoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Pet Cancer Therapeutics (Mammary and Squamous Cell Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Pet Cancer Therapeutics (Mammary and Squamous Cell Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Pet Cancer Therapeutics (Other Cancer Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Pet Cancer Therapeutics (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Pet Cancer Therapeutics (Veterinary Hospitals and Clinical Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Pet Cancer Therapeutics (Veterinary Hospitals and Clinical Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Pet Cancer Therapeutics (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Pet Cancer Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Pet Cancer Therapeutics (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Pet Cancer Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Pet Cancer Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Pet Cancer Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia-Pacific: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia-Pacific: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Pet Cancer Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Pet Cancer Therapeutics Market: Breakup by Country (in %), 2021
Figure 91: Middle East and Africa: Pet Cancer Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Global: Pet Cancer Therapeutics Industry: SWOT Analysis
Figure 93: Global: Pet Cancer Therapeutics Industry: Value Chain Analysis
Figure 94: Global: Pet Cancer Therapeutics Industry: Porter's Five Forces Analysis
